🕵️ VOR Biopharma Inc. ($VOR)
SEC insider & ownership activity, last 12 months · CIK 1817229 · every row links its SEC filing
Over the last 12 months insiders sold $99.6M with no open-market buying against it. RA Capital Management, L.P. sold $83.1M (Oct–Jul). RA Capital Management, L.P. trimmed 31.9% → 19.9%; Peter Kolchinsky trimmed 31.9% → 19.9%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $99.6M (73 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 0 | – | 44 | $83.1M | Jul 16, 2026 |
| Reprogrammed Interchange LLC | 0 | – | 29 | $16.5M | Oct 21, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 19.9% | 13D | Jul 16, 2026 | filing ↗ | |
| Peter Kolchinsky | 19.9% | 13D | Jul 16, 2026 | filing ↗ | |
| Rajeev Shah | 19.9% | 13D | Jul 16, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 19.9% | 13D | Jul 16, 2026 | filing ↗ | |
| Reid Hoffman | 17.6% | 13D | Oct 15, 2025 | filing ↗ | |
| Reprogrammed Interchange LLC | 17.6% | 13D | Oct 15, 2025 | filing ↗ | |
| FMR LLC | 12.0% | 13G | Aug 7, 2026 | filing ↗ | |
| Abigail P. Johnson | 12.0% | 13G | Aug 7, 2026 | filing ↗ | |
| Chen Yu | 10.5% | 13G | Apr 1, 2026 | filing ↗ | |
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 10.0% | 13D | Dec 18, 2025 | filing ↗ | |
| Forbion Growth III Management B.V. | 10.0% | 13D | Dec 18, 2025 | filing ↗ | |
| ForGrowth III Pa B.v. | 10.0% | 13D | Dec 18, 2025 | filing ↗ | |
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| VHCP Co-Investment Holdings III, LLC | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Venrock Healthcare Capital Partners EG, L.P. | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| VHCP Management III, LLC | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| VHCP Management EG, LLC | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Nimish Shah | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Bong Y. Koh | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Verve Capital Limited | 6.3% | 13G | Aug 13, 2026 | filing ↗ | |
| BlackRock, Inc. | 5.7% | 13G | Jul 30, 2026 | filing ↗ | |
| TCG Crossover GP II, LLC | 5.2% | 13G | Apr 1, 2026 | filing ↗ | |
| TCG Crossover Fund II, L.P. | 5.2% | 13G | Apr 1, 2026 | filing ↗ | |
| TCG Crossover GP III, LLC | 5.2% | 13G | Apr 1, 2026 | filing ↗ | |
| TCG Crossover Fund III, L.P. | 5.2% | 13G | Apr 1, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| RA Capital Nexus Fund, L.P. | $445K | Oct 20, 2025 | filing ↗ |
| RA Capital Healthcare Fund LP | $2.3M | Oct 20, 2025 | filing ↗ |
| RA Capital Nexus Fund, L.P. | $1.2M | Oct 17, 2025 | filing ↗ |
| RA Capital Healthcare Fund LP | $6.3M | Oct 17, 2025 | filing ↗ |
| RA Capital Nexus Fund, L.P. | $724K | Oct 16, 2025 | filing ↗ |
| RA Capital Healthcare Fund LP | $3.7M | Oct 16, 2025 | filing ↗ |
| RA Capital Nexus Fund, L.P. | $255K | Oct 15, 2025 | filing ↗ |
| RA Capital Healthcare Fund LP | $1.3M | Oct 15, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 6, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 8, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 26, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 31, 2025 | filing ↗ |
| Material agreement (1.01) | Dec 15, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 15, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 15, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 15, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 15, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 5, 2025 | filing ↗ |
| Other events (8.01) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 2, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 2, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 2, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 28, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Sep 17, 2025 | filing ↗ |
| Other events (8.01) | Sep 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 17, 2025 | filing ↗ |